0.00
price down icon100.00%   -1.74
after-market Dopo l'orario di chiusura: 1.77 1.77 +
loading

Lava Therapeutics Nv Borsa (LVTX) Ultime notizie

pulisher
Dec 08, 2025

What analysts say about LAVA Therapeutics NV 4PKB stockMarket Breadth Indicators & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Dec 08, 2025
pulisher
Dec 04, 2025

Total debt per share of LAVA Therapeutics NV – BER:4PKB - TradingView

Dec 04, 2025
pulisher
Dec 04, 2025

Operating cash flow per share of LAVA Therapeutics NV – SWB:4PKB - TradingView

Dec 04, 2025
pulisher
Dec 04, 2025

Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsMarket Activity Recap & Daily Volume Surge Signals - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Why LAVA Therapeutics N.V. (4PKB) stock is listed among top recommendations2025 Growth vs Value & Daily Stock Trend Reports - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Is LAVA Therapeutics NV technically bullish or bearish? - Markets Mojo

Dec 02, 2025
pulisher
Dec 02, 2025

LAVA Therapeutics (LVTX) Expected to Announce Earnings on Tuesday - Defense World

Dec 02, 2025
pulisher
Nov 27, 2025

LAVA Therapeutics NV Financial Disclosures & Filings - TradingView

Nov 27, 2025
pulisher
Nov 24, 2025

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - ADVFN

Nov 24, 2025
pulisher
Nov 21, 2025

XOMA Royalty completes acquisition of LAVA Therapeutics By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

Lava Therapeutics shares delisted from Nasdaq following completion of acquisition - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

Lava Therapeutics shares delisted from Nasdaq following completion of acquisition By Investing.com - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 21, 2025

XOMA Completes Acquisition of LAVA Therapeutics - TipRanks

Nov 21, 2025
pulisher
Nov 21, 2025

[SC TO-T/A] LAVA Therapeutics NV Amended Third-Party Tender Offer | LVTX SEC FilingForm SC TO-T/A - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

XOMA Royalty completes acquisition of LAVA Therapeutics - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

LAVA Therapeutics Announces Executive Departures - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[8-K] LAVA Therapeutics NV Reports Material Event | LVTX SEC FilingForm 8-K - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Xoma Royalty announces closing of transactions to acquire LAVA Therapeutics N.V. - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

XOMA Royalty Corporation Completes Acquisition of LAVA Therapeutics N.V. - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

XOMA Royalty (Nasdaq: XOMA) completes LAVA deal; investors get $1.04 plus CVR - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Will LAVA Therapeutics N.V. stock benefit from AI adoption2025 Big Picture & Weekly High Return Opportunities - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What makes LAVA Therapeutics N.V. (4PKB) stock appealing to growth investorsIPO Watch & High Return Stock Watch Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

EBIT per share of LAVA Therapeutics NV – MUN:4PKB - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

LAVA Therapeutics N.V.(NasdaqGS: LVTX) dropped from NASDAQ Composite Index - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

How LAVA Therapeutics N.V. (4PKB) stock expands through international markets2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How LAVA Therapeutics N.V. (4PKB) stock trades in high volatilityChart Signals & Proven Capital Preservation Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How LAVA Therapeutics N.V. stock performs during Fed tightening cyclesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will LAVA Therapeutics N.V. (4PKB) stock outperform small cap peersMarket Performance Report & Verified Stock Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

LAVA Therapeutics NV (4PKB.MU) Latest Press Releases & Corporate News - Yahoo! Finance Canada

Nov 20, 2025
pulisher
Nov 20, 2025

Will LAVA Therapeutics N.V. (4PKB) stock justify high valuationWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Setups & Entry Point Confirmation Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Sell Signal & High Yield Stock Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will LAVA Therapeutics N.V. stock benefit from green energy trendsWall Street Watch & Expert Curated Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to track smart money flows in LAVA Therapeutics N.V.2025 Winners & Losers & Daily Profit Focused Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is LAVA Therapeutics N.V. showing signs of accumulationWall Street Watch & Reliable Intraday Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How LAVA Therapeutics N.V. stock valuations compare to rivals2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why LAVA Therapeutics N.V. (4PKB) stock stays on buy listsWeekly Trade Analysis & Safe Swing Trade Setups - newser.com

Nov 19, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):